PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy

Elshafei A., Chevli K. K., Moussa A. S., Kara Ö., Chueh S., Walter P., ...Daha Fazla

PROSTATE, cilt.75, sa.16, ss.1951-1957, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 75 Sayı: 16
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1002/pros.23096
  • Dergi Adı: PROSTATE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1951-1957
  • Anahtar Kelimeler: PCA3 nomogram, prostate cancer, prostate biopsy, ANTIGEN 3, VALIDATION, PCA3, MANAGEMENT, MORTALITY, ASSAY, RISK, GENE, MEN
  • Kocaeli Üniversitesi Adresli: Hayır

Özet

BACKGROUNDTo develop a validated prostate cancer antigen 3 (PCA3) based nomogram that predicts likelihood of overall prostate cancer (PCa) and intermediate/high grade prostate cancer (HGPCa) in men pursuing initial transrectal prostate biopsy (TRUS-PBx).